Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 27 December 2023
Adhoc Press Release
Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
Press Release, 28 November 2023
Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
Press Release, 12 October 2023
Adhoc Press Release
Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
Press Release, 9 August 2023
Adhoc Press Release
Kuros Biosciences Reports Results for First Half 2023
Kuros Interim Results, 2023
English version
Press Release, 13 July 2023
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
media-investors
2023